272 related articles for article (PubMed ID: 35632742)
21. Laryngeal reconstruction in children with recurrent respiratory papillomatosis.
Scatolini ML; Cocciaglia A; Pérez CG; Rodríguez HA
Int J Pediatr Otorhinolaryngol; 2018 Dec; 115():120-124. PubMed ID: 30368371
[TBL] [Abstract][Full Text] [Related]
22. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
24. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.
Spurgeon ME; Lambert PF
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051276
[TBL] [Abstract][Full Text] [Related]
25. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
[TBL] [Abstract][Full Text] [Related]
26. Clinical and treatment course of lung carcinoma from adult-onset recurrent respiratory papillomatosis with lung involvement: A case report.
Cardoso Figueiredo M; Chantre-Justino M; Latini Ruback R; Pires de Mello P; Alves G; Helena Ornellas M
Oral Oncol; 2021 Oct; 121():105398. PubMed ID: 34167900
[TBL] [Abstract][Full Text] [Related]
27. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
29. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
30. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study).
Formánek M; Jančatová D; Komínek P; Matoušek P; Zeleník K
Clin Otolaryngol; 2017 Jun; 42(3):597-601. PubMed ID: 27759910
[TBL] [Abstract][Full Text] [Related]
31. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts.
Best SR; Esquivel D; Mellinger-Pilgrim R; Roden RBS; Pitman MJ
Laryngoscope; 2020 Mar; 130(3):712-717. PubMed ID: 31041820
[TBL] [Abstract][Full Text] [Related]
32. Recurrent respiratory papillomatosis arising in trachea not affecting larynx.
Xue Q; Wang J
Intern Med; 2010; 49(15):1649-51. PubMed ID: 20686308
[TBL] [Abstract][Full Text] [Related]
33. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
34. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
35. Rodent Papillomaviruses.
Uberoi A; Lambert PF
Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
[TBL] [Abstract][Full Text] [Related]
36. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
37. Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.
Kimberlin DW; Malis DJ
Antiviral Res; 2000 Feb; 45(2):83-93. PubMed ID: 10809017
[TBL] [Abstract][Full Text] [Related]
38. Recurrent respiratory papillomatosis.
Venkatesan NN; Pine HS; Underbrink MP
Otolaryngol Clin North Am; 2012 Jun; 45(3):671-94, viii-ix. PubMed ID: 22588043
[TBL] [Abstract][Full Text] [Related]
39. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract].
Velyvyte D; Laiskonis A; Uloza V; Gozdzicka-Jozefiak A
Medicina (Kaunas); 2002; 38(5):499-504. PubMed ID: 12474680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
